Insulin glargine 300 U/mL versus first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 12‐month outcomes of ACHIEVE Control, a prospective, randomi...

por Meneghini, Luigi, Blonde, Lawrence, Gill, Jasvinder, Dauchy, Arnaud, Bacevicius, Andrius, Strong, Jodi, Bailey, Timothy S.
Publicado 2020

A pragmatic randomized clinical trial of insulin glargine 300 U/mL vs first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 6‐month outcomes of the...

por Meneghini, Luigi F., Sullivan, Sean D., Oster, Gerry, Busch, Robert, Cali, Anna M. G., Dauchy, Arnaud, Gill, Jasvinder, Bailey, Timothy S.
Publicado 2020

Take Control: A randomized trial evaluating the efficacy and safety of self‐ versus physician‐managed titration of insulin glargine 300 U/mL in patients with uncontrolled type 2 di...

por Russell‐Jones, David, Dauchy, Arnaud, Delgado, Elías, Dimitriadis, George, Frandsen, Hans A., Popescu, Luiza, Schultes, Bernd, Strojek, Krzysztof, Bonnemaire, Mireille, Roborel de Climens, Aude, Davies, Melanie
Publicado 2019